)
Visual
test
OptimizeRx
OptimizeRx (OPRX) investor relations material
OptimizeRx Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary6 Nov, 2025
Executive summary
Q3 2025 revenue increased 22% year-over-year to $26.1M, with gross profit up 30% to $17.5M, driven by growth in DTC and DAAP sales.
Net income was $0.8M for Q3 2025, compared to a net loss of $9.1M in Q3 2024; non-GAAP net income was $3.9M, up from $2.3M.
Operating expenses decreased 30% year-over-year in Q3 2025, mainly due to lower stock-based compensation and no goodwill impairment.
Adjusted EBITDA for Q3 2025 increased to $5.1M from $2.7M a year ago.
Strong operational and financial momentum continues, supported by a patient-focused strategy and improved revenue visibility.
Financial highlights
Revenue for the nine months ended September 30, 2025, was $77.2M, up from $59.8M in the prior year period.
Gross margin for Q3 2025 was approximately 67%, up from 63% in Q3 2024, driven by favorable product and channel mix.
Cost of revenues as a percentage of revenue decreased to 33% in Q3 2025 from 37% in Q3 2024.
Cash and cash equivalents rose to $19.5M at September 30, 2025, up from $13.4M at year-end 2024.
Net cash provided by operating activities was $11.6M for the nine months ended September 30, 2025, up from $4.7M in the prior year period.
Outlook and guidance
Fiscal year 2025 revenue guidance raised to $105–$109M, with adjusted EBITDA expected between $16–$19M.
Initial 2026 guidance: revenue of $118–$124M and adjusted EBITDA of $19–$22M, based on contracted business and conservative assumptions.
Guidance excludes potential upside from new partnerships such as Lamar Advertising.
Revenue model enhancements and a shift to subscription-based contracts provide greater predictability and smoother revenue recognition.
Gross margins are expected to stabilize in the upper 50s to low 60s percentage range, with potential upside as the business scales.
Explain the shift in top 20 pharma revenue mix
Capital allocation strategy given debt paydown
Address the decline in net revenue retention
Explain new guidance's upside potential?
How does new model improve 2026 visibility?
When will Lamar partnership impact guidance?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 032640
Net profit surged 61.9% YoY on strong wireless, broadband, and AIDC growth. - S68
Record revenue, robust segment growth, and strong IPO pipeline drive positive outlook. - 6723
AI and industrial demand drive growth, timing business sold, inventory targets raised. - 6417
Strong pachinko sales drove revenue growth, with major treasury stock cancellation planned. - BPT
H1 FY26 revenue hit $1B, with strong gas prices and LNG cargoes offsetting lower production. - CPAY
Record 2025 results and 2026 outlook driven by strong segment growth and capital deployment. - LOT
A$76M equity raise supports Kayelekera ramp-up and Letlhakane development amid strong uranium demand. - SYM
Revenue up 29% to $630M, net income $13.36M, $22.3B backlog, strong cash, legal risks persist. - TENB
Record 2025 results with double-digit growth, strong cash flow, and expanding AI-driven platform. - DHX
Q4 2025 revenue down 10% YoY; FY 2026 guidance targets $118M–$122M revenue.
Next OptimizeRx earnings date
Q4 202512 Mar, 2026
OptimizeRx
Next OptimizeRx earnings date
Q4 202512 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
OptimizeRx Corporation provides software solutions that help doctors and their staff to improve communication with patients through various mobile channels. It also enables pharmacies to integrate patient support programs directly into the pharmacy workflow. In addition, the company offers electronic coupon technology, which enables pharma companies to securely and seamlessly deliver a variety of valuable offers for their products directly to prescribers within their existing workflows. The company was found in 2006 and is headquartered in Rochester, Michigan.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage